Jul 20, 2011

HIV/AIDS: More Proof that PrEP Works


A recent study provided overwhelming evidence supporting HIV-negative partners in a heterosexual relationship with an HIV-positive individual (discordant couple) taking a daily dose of antiretroviral treatment. The Partner PrEP (Pre-exposure Prophylaxis) study showed that HIV-negative partners in Kenya and Uganda taking a combination of tenofovir and emtricitabine had 73% fewer infections compared to partners taking the placebo treatment. The results were supported by a similar study conducted by the Centers for Disease Control finding the combination treatment to reduce risk of HIV infection by 62% among partners in Botswana. The results suggest that national governments should integrate PrEP into HIV policy. However, WHO representatives stated the outcomes are encouraging for the HIV prevention and treatment movement yet integrating the practice into policy should be done with caution. This method of identifying HIV-negative persons with HIV-positive partners can lead to creating stigma. Additionally, with less than half of some communities' populations not knowing their HIV status, identifying those at risk of infection is even more difficult. But overall, the potential to change the epidemic is remarkable. Life for Mothers is beginning to reduce such hindrances as knowing one’s HIV status by increasing the percent of men and women being tested for HIV through community outreach. Through education and awareness, Life for Mothers hopes to reduce stigma related to HIV status, PMTCT, and HIV transmission between partners. This should help pave the way for future policies such as Partner PrEP to be more readily accepted. To read the full article, click here


Did you know?

Almost every minute, a woman dies related to complications related to pregnancy and childbirth.

Source:United Nations Department of Public Information

Franck Muller USA
is a proud sponsor of